Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Fair Isaac Corp a un objectif de cours consensus de $1850, basé sur les évaluations des 18 analystes. Le plus élevé est de $2661 attribué par Goldman Sachs le décembre 5, 2024, et le plus bas est de $729 attribué par HSBC le septembre 29, 2023. Les 3 dernières évaluations d'analystes ont été publiées par Wells Fargo, Barclays et Needham le octobre 14, 2025, octobre 2, 2025 et octobre 2, 2025. Avec un objectif de cours moyen de $2250 entre Wells Fargo, Barclays et Needham, il y a une variation implicite de 34.96% upside pour Fair Isaac Corp à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/14/2025 | 43.95% | Wells Fargo | $2300 → $2400 | Maintains | Overweight | |||
10/02/2025 | 43.95% | Barclays | $2000 → $2400 | Maintains | Overweight | |||
10/02/2025 | 16.96% | Needham | $1950 → $1950 | Reiterates | Buy → Buy | |||
10/01/2025 | 7.97% | Seaport Global | → $1800 | Initiates | → Buy | |||
09/15/2025 | -1.63% | UBS | $1590 → $1640 | Maintains | Neutral | |||
09/08/2025 | -4.63% | UBS | $1540 → $1590 | Maintains | Neutral | |||
08/18/2025 | 7.97% | BMO Capital | $1650 → $1800 | Maintains | Outperform | |||
08/04/2025 | -1.03% | BMO Capital | $1800 → $1650 | Maintains | Outperform | |||
07/31/2025 | 7.97% | Raymond James | $2230 → $1800 | Maintains | Outperform | |||
07/31/2025 | 17.14% | Oppenheimer | $2300 → $1953 | Maintains | Outperform | |||
07/16/2025 | 16.96% | Needham | $2575 → $1950 | Maintains | Buy | |||
07/10/2025 | 19.96% | BMO Capital | → $2000 | Initiates | → Outperform | |||
07/09/2025 | 19.96% | Barclays | $2250 → $2000 | Maintains | Overweight | |||
07/09/2025 | 37.96% | Wells Fargo | $2600 → $2300 | Maintains | Overweight | |||
07/08/2025 | 37.96% | Oppenheimer | $2293 → $2300 | Maintains | Outperform | |||
06/20/2025 | 54.45% | Needham | $2575 → $2575 | Reiterates | Buy → Buy | |||
06/10/2025 | 54.45% | Needham | $2575 → $2575 | Reiterates | Buy → Buy | |||
05/28/2025 | 13.96% | Baird | $2021 → $1900 | Upgrade | Neutral → Outperform | |||
05/14/2025 | 49.95% | Jefferies | $2225 → $2500 | Maintains | Buy | |||
05/12/2025 | 54.45% | Needham | $2500 → $2575 | Maintains | Buy | |||
05/08/2025 | 37.54% | Oppenheimer | $2116 → $2293 | Maintains | Outperform | |||
04/30/2025 | 10.19% | Baird | $1775 → $1837 | Maintains | Neutral | |||
04/30/2025 | 33.76% | Raymond James | $2030 → $2230 | Maintains | Outperform | |||
04/30/2025 | 49.95% | Needham | $2500 → $2500 | Reiterates | Buy → Buy | |||
04/11/2025 | 49.95% | Needham | $2500 → $2500 | Reiterates | Buy → Buy | |||
04/04/2025 | 34.96% | Barclays | $2350 → $2250 | Maintains | Overweight | |||
02/26/2025 | 30.16% | RBC Capital | $2040 → $2170 | Upgrade | Sector Perform → Outperform | |||
02/05/2025 | 16.96% | UBS | $2100 → $1950 | Maintains | Neutral | |||
02/05/2025 | 55.95% | Wells Fargo | $2650 → $2600 | Maintains | Overweight | |||
02/05/2025 | 6.47% | Baird | $1975 → $1775 | Maintains | Neutral | |||
02/05/2025 | 30.46% | Jefferies | $2275 → $2175 | Maintains | Buy | |||
02/05/2025 | 49.95% | Needham | $2500 → $2500 | Reiterates | Buy → Buy | |||
01/27/2025 | 25.96% | UBS | $2250 → $2100 | Maintains | Neutral | |||
01/15/2025 | 36.46% | Jefferies | $2250 → $2275 | Maintains | Buy | |||
01/13/2025 | 34.96% | UBS | $2100 → $2250 | Maintains | Neutral | |||
01/07/2025 | 44.49% | Oppenheimer | $2515 → $2409 | Maintains | Outperform | |||
12/20/2024 | 28.96% | JP Morgan | → $2150 | Initiates | → Neutral | |||
12/05/2024 | 59.61% | Goldman Sachs | $2374 → $2661 | Maintains | Buy | |||
12/02/2024 | 50.85% | Oppenheimer | $2324 → $2515 | Maintains | Outperform | |||
11/07/2024 | 49.95% | Needham | $1850 → $2500 | Maintains | Buy | |||
11/07/2024 | 19.96% | Baird | $1700 → $2000 | Maintains | Neutral | |||
11/07/2024 | 42.4% | Goldman Sachs | $2130 → $2374 | Maintains | Buy | |||
11/07/2024 | 22.36% | RBC Capital | $2040 → $2040 | Reiterates | Sector Perform → Sector Perform | |||
11/07/2024 | 43.95% | Wells Fargo | $2200 → $2400 | Maintains | Overweight | |||
11/07/2024 | 40.96% | Barclays | $2150 → $2350 | Maintains | Overweight | |||
10/08/2024 | 26.5% | Oppenheimer | $1967 → $2109 | Maintains | Outperform | |||
10/02/2024 | 27.76% | Goldman Sachs | $1879 → $2130 | Maintains | Buy | |||
10/01/2024 | 31.96% | Wells Fargo | $2100 → $2200 | Maintains | Overweight | |||
10/01/2024 | 25.96% | UBS | → $2100 | Initiates | → Neutral | |||
09/13/2024 | 28.96% | Barclays | $1800 → $2150 | Maintains | Overweight | |||
09/03/2024 | 17.98% | Oppenheimer | → $1967 | Initiates | → Outperform | |||
08/12/2024 | 25.96% | Wells Fargo | → $2100 | Initiates | → Overweight | |||
08/07/2024 | 7.97% | Barclays | $1500 → $1800 | Maintains | Overweight | |||
08/01/2024 | 10.97% | Needham | $1500 → $1850 | Maintains | Buy | |||
08/01/2024 | -10.03% | RBC Capital | $1350 → $1500 | Maintains | Sector Perform | |||
08/01/2024 | 1.97% | Baird | $1264 → $1700 | Maintains | Neutral | |||
07/09/2024 | 3.47% | Wolfe Research | → $1725 | Initiates | → Outperform | |||
06/11/2024 | -10.03% | Needham | $1500 → $1500 | Reiterates | Buy → Buy | |||
04/26/2024 | -10.03% | Needham | $1500 → $1500 | Reiterates | Buy → Buy | |||
04/26/2024 | -14.95% | Raymond James | $1413 → $1418 | Maintains | Outperform | |||
04/22/2024 | -10.03% | Needham | $1500 → $1500 | Reiterates | Buy → Buy | |||
04/16/2024 | -33.24% | Redburn Atlantic | → $1113 | Initiates | → Neutral | |||
01/26/2024 | -19.03% | RBC Capital | $1350 → $1350 | Reiterates | Sector Perform → Sector Perform | |||
01/26/2024 | -10.03% | Barclays | $1234 → $1500 | Maintains | Overweight | |||
01/26/2024 | -16.03% | Raymond James | $1214 → $1400 | Maintains | Outperform | |||
01/26/2024 | -10.03% | Needham | $1100 → $1500 | Maintains | Buy | |||
01/26/2024 | -10.03% | Needham | $1100 → $1500 | Maintains | Buy | |||
01/17/2024 | -13.03% | Jefferies | $1210 → $1450 | Maintains | Buy | |||
01/10/2024 | -27.18% | Raymond James | $1029 → $1214 | Maintains | Outperform | |||
12/05/2023 | -22.68% | Goldman Sachs | $1156 → $1289 | Maintains | Buy | |||
12/04/2023 | -22.68% | Goldman Sachs | $1156 → $1289 | Maintains | Buy | |||
11/14/2023 | -25.98% | Barclays | $950 → $1234 | Maintains | Overweight | |||
11/09/2023 | -47.52% | RBC Capital | → $875 | Reiterates | Sector Perform → Sector Perform | |||
11/09/2023 | -38.28% | Raymond James | $975 → $1029 | Maintains | Outperform | |||
11/08/2023 | — | Wells Fargo | — | Initiates | → Overweight | |||
10/25/2023 | -41.52% | Raymond James | $1007 → $975 | Maintains | Outperform | |||
09/29/2023 | -56.27% | HSBC | → $729 | Initiates | → Reduce | |||
09/06/2023 | -39.6% | Raymond James | → $1007 | Initiates | → Outperform | |||
08/03/2023 | -47.52% | RBC Capital | $685 → $875 | Maintains | Sector Perform | |||
08/03/2023 | -43.02% | Barclays | $920 → $950 | Maintains | Overweight | |||
08/03/2023 | -34.02% | Needham | $900 → $1100 | Maintains | Buy | |||
06/08/2023 | -46.02% | Needham | $855 → $900 | Maintains | Buy | |||
05/22/2023 | -53.51% | Baird | $725 → $775 | Maintains | Neutral | |||
05/22/2023 | -44.82% | Barclays | $820 → $920 | Maintains | Overweight | |||
05/22/2023 | -48.72% | Needham | $825 → $855 | Maintains | Buy | |||
05/02/2023 | -47.52% | Jefferies | $745 → $875 | Maintains | Buy | |||
04/28/2023 | -54.47% | Deutsche Bank | $743 → $759 | Maintains | Buy | |||
04/28/2023 | -56.51% | Baird | $655 → $725 | Maintains | Neutral | |||
04/28/2023 | -50.82% | Barclays | $700 → $820 | Maintains | Overweight | |||
04/28/2023 | -50.52% | Needham | $780 → $825 | Maintains | Buy | |||
02/13/2023 | -53.21% | Needham | → $780 | Maintains | Buy | |||
01/27/2023 | -56.81% | Deutsche Bank | $697 → $720 | Maintains | Buy | |||
01/27/2023 | -58.91% | RBC Capital | $463 → $685 | Maintains | Sector Perform | |||
01/27/2023 | -55.31% | Jefferies | $715 → $745 | Maintains | Buy | |||
01/27/2023 | -51.6% | Goldman Sachs | $709 → $807 | Maintains | Buy | |||
01/27/2023 | -60.71% | Baird | $537 → $655 | Maintains | Neutral | |||
01/27/2023 | -53.21% | Needham | $630 → $780 | Reiterates | → Buy | |||
12/12/2022 | -58.85% | Goldman Sachs | $614 → $686 | Maintains | Buy | |||
12/02/2022 | -58.01% | Barclays | $575 → $700 | Maintains | Overweight | |||
11/11/2022 | -58.31% | Jefferies | $545 → $695 | Maintains | Buy |
Le dernier objectif de prix pour Fair Isaac (NYSE:FICO) a été rapporté par Wells Fargo le octobre 14, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $2400.00 s'attendant à ce que FICO se rise dans les 12 prochains mois (un possible changement de 43.95% upside). 45 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Fair Isaac (NYSE:FICO) a été fournie par Wells Fargo, et Fair Isaac maintenu leur note overweight.
La dernière amélioration pour Fair Isaac Corp a eu lieu le mai 28, 2025 lorsque Baird a augmenté leur objectif de prix à $1900. Baird avait précédemment a neutral pour Fair Isaac Corp.
Il n'y a pas de dernière réduction pour Fair Isaac.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Fair Isaac, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Fair Isaac a été déposée le octobre 14, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 14, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Fair Isaac (FICO) était un maintenu avec un objectif de prix de $2300.00 à $2400.00. Le prix actuel de Fair Isaac (FICO) est de $1667.19, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.